positionForPages[125]={page:125,positions:[{w:"117",p:[0.890196,0.957873,0.912819,0.957873,0.912819,0.938882,0.890196,0.938882,0.006807,0.007226,0.008591]},{w:"5",p:[0.941813,0.435294,0.963291,0.435294,0.963291,0.387816,0.941813,0.387816,0.021478]},{w:"OPTIMIZING NANOPORE SEQUENCING-BASED DETECTION OF STRUCTURAL VARIANTS ENABLES",p:[0.340931,0.057372,0.882352,0.057372,0.882352,0.040253,0.340931,0.040253,0.008442,0.007975,0.006387,0.003511,0.011112,0.003511,0.006630,0.003511,0.008759,0.008404,0.002988,0.008759,0.007919,0.008759,0.008442,0.008050,0.008442,0.008423,0.006985,0.002988,0.007807,0.006985,0.008442,0.008367,0.006985,0.008759,0.008255,0.003511,0.008759,0.008404,0.005155,0.008121,0.007713,0.007807,0.006985,0.008423,0.002988,0.008423,0.006985,0.006387,0.006985,0.008178,0.006387,0.003511,0.008442,0.008759,0.002988,0.008442,0.006593,0.002988,0.007732,0.006387,0.008367,0.008367,0.008180,0.006387,0.008367,0.008423,0.007919,0.006292,0.002801,0.006966,0.007919,0.008423,0.003511,0.007919,0.008759,0.006313,0.007807,0.002988,0.006985,0.008759,0.007919,0.008236,0.006481,0.006871,0.007807]},{w:"INDIVIDUALIZED CIRCULATING TUMOR DNA-BASED DISEASE MONITORING IN CANCER PATIENTS",p:[0.337347,0.073247,0.882352,0.073247,0.882352,0.056128,0.337347,0.056128,0.003511,0.008759,0.008423,0.003511,0.007620,0.003511,0.008423,0.008253,0.007919,0.006481,0.003511,0.006630,0.006985,0.008423,0.002988,0.008255,0.003511,0.008309,0.008255,0.008367,0.006481,0.007097,0.006387,0.003511,0.008759,0.008404,0.002988,0.006387,0.008367,0.011112,0.008442,0.008423,0.002988,0.008423,0.008759,0.007543,0.005155,0.008124,0.007713,0.007807,0.006985,0.008423,0.002988,0.008423,0.003511,0.007807,0.006985,0.007713,0.007807,0.006985,0.002988,0.011112,0.008442,0.008759,0.003511,0.006311,0.008442,0.008423,0.003511,0.008759,0.008404,0.002988,0.003511,0.008759,0.002988,0.008178,0.007919,0.008759,0.008255,0.006985,0.008423,0.002988,0.007581,0.007099,0.006387,0.003511,0.006985,0.008759,0.006311,0.007807]},{w:"Abstract",p:[0.147059,0.126494,0.242873,0.126494,0.242873,0.098384,0.147059,0.098384,0.012318,0.012812,0.012028,0.010343,0.013103,0.012144,0.012725,0.010343]},{w:"Somatic genomic structural variations (SVs) are promising personalized biomarkers to ",p:[0.147059,0.171137,0.886441,0.171137,0.886441,0.150764,0.147059,0.150764,0.010592,0.010843,0.017577,0.008811,0.006437,0.005547,0.008994,0.005136,0.009656,0.009039,0.011596,0.010843,0.017645,0.005547,0.008994,0.005136,0.007510,0.006437,0.007967,0.011345,0.009108,0.006163,0.011413,0.007898,0.009405,0.005250,0.005136,0.009838,0.009085,0.007807,0.005798,0.008811,0.006437,0.005547,0.010843,0.011619,0.007670,0.005136,0.006939,0.010112,0.015089,0.007670,0.006939,0.005136,0.009085,0.007442,0.009039,0.005136,0.011071,0.007442,0.010843,0.017645,0.005615,0.007601,0.005615,0.011459,0.009861,0.005136,0.011505,0.009039,0.007624,0.007875,0.010843,0.011687,0.009405,0.005250,0.005615,0.008834,0.009108,0.011391,0.005136,0.010820,0.005545,0.010845,0.017577,0.009085,0.007601,0.010272,0.009039,0.007624,0.007670,0.005136,0.006209,0.011048,0.004109]},{w:"quantify circulating tumor DNA (ctDNA) in liquid biopsies as they represent unique ",p:[0.147059,0.191716,0.886532,0.191716,0.886532,0.171343,0.147059,0.171343,0.010706,0.011596,0.009085,0.011391,0.006437,0.005615,0.006506,0.009724,0.006414,0.008994,0.005615,0.007442,0.009108,0.011550,0.005433,0.008811,0.006437,0.005615,0.011459,0.009861,0.006414,0.006163,0.011413,0.017485,0.010843,0.007807,0.006414,0.015773,0.015408,0.014929,0.006414,0.006939,0.009108,0.006437,0.015771,0.015410,0.014929,0.006939,0.006414,0.005615,0.011756,0.006414,0.005250,0.005547,0.010706,0.011413,0.005547,0.011391,0.006414,0.010820,0.005547,0.010820,0.011185,0.007601,0.005547,0.009039,0.007670,0.006414,0.009291,0.007670,0.006414,0.006620,0.011299,0.009336,0.009724,0.006414,0.007442,0.009131,0.011071,0.007442,0.009039,0.007875,0.009039,0.011391,0.006437,0.006414,0.011413,0.011756,0.005547,0.010706,0.011345,0.009039,0.004109]},{w:"tumor derived molecules. However, in most solid malignancies these SVs are variable ",p:[0.147059,0.212294,0.886535,0.212294,0.886535,0.191922,0.147059,0.191922,0.006163,0.011413,0.017485,0.010843,0.007807,0.006049,0.011322,0.009039,0.007807,0.005547,0.009633,0.009108,0.011391,0.006049,0.017485,0.010934,0.005184,0.009106,0.009108,0.011550,0.005182,0.009039,0.007670,0.004497,0.006049,0.016207,0.010866,0.014518,0.009336,0.009633,0.009039,0.006255,0.004497,0.006049,0.005615,0.011756,0.006049,0.017485,0.010959,0.007510,0.006437,0.006049,0.007875,0.010934,0.005250,0.005547,0.011391,0.006049,0.017577,0.009405,0.005250,0.005615,0.009861,0.011685,0.009087,0.011596,0.008994,0.005547,0.009039,0.007670,0.006049,0.006620,0.011299,0.009039,0.007875,0.009039,0.006049,0.010112,0.015089,0.007670,0.006049,0.009085,0.007442,0.009039,0.006049,0.009838,0.009085,0.007807,0.005798,0.009108,0.010911,0.005182,0.009039,0.004109]},{w:"and can be located anywhere in the genome thus the complexity of the identification of ",p:[0.147059,0.232873,0.886464,0.232873,0.886464,0.212500,0.147059,0.212500,0.009085,0.011596,0.011391,0.004679,0.009108,0.009085,0.011756,0.004679,0.011254,0.009039,0.004679,0.005182,0.011276,0.009108,0.008811,0.006209,0.009108,0.011391,0.004679,0.009085,0.011368,0.010272,0.014789,0.011302,0.009039,0.007442,0.009039,0.004679,0.005615,0.011756,0.004679,0.006620,0.011299,0.009039,0.004679,0.009656,0.009039,0.011596,0.010843,0.017485,0.009039,0.004679,0.006620,0.011094,0.011413,0.007670,0.004679,0.006620,0.011299,0.009039,0.004679,0.008994,0.010843,0.017280,0.011162,0.005182,0.009108,0.010089,0.005273,0.006437,0.009724,0.004679,0.010843,0.006209,0.004679,0.006620,0.011299,0.009039,0.004679,0.005547,0.011322,0.009039,0.011391,0.006437,0.005615,0.005684,0.005615,0.009108,0.008811,0.006437,0.005547,0.010843,0.011756,0.004679,0.010843,0.006209,0.004109]},{w:"personalized SVs hinders routine use in the clinic. Here, we developed a novel approach ",p:[0.147059,0.253452,0.886393,0.253452,0.886393,0.233079,0.147059,0.233079,0.011505,0.009039,0.007624,0.007875,0.010843,0.011687,0.009405,0.005250,0.005615,0.008834,0.009106,0.011391,0.004109,0.010112,0.015089,0.007670,0.004109,0.011459,0.005615,0.011596,0.011322,0.009039,0.007624,0.007670,0.004109,0.007442,0.010820,0.011071,0.006437,0.005615,0.011596,0.009039,0.004109,0.011413,0.007873,0.009039,0.004109,0.005615,0.011756,0.004109,0.006620,0.011299,0.009039,0.004109,0.008765,0.005250,0.005615,0.011756,0.005547,0.008994,0.004497,0.004109,0.016207,0.009039,0.007442,0.008743,0.004497,0.004109,0.014518,0.009039,0.004109,0.011322,0.009336,0.009633,0.008948,0.005182,0.010820,0.011505,0.009108,0.011391,0.004109,0.009291,0.004109,0.011598,0.010863,0.009635,0.008948,0.005250,0.004109,0.008811,0.011048,0.011071,0.007442,0.011139,0.009291,0.008765,0.011459,0.004109]},{w:"for rapid discovery of a set of patient-specific somatic SVs. We combine low coverage ",p:[0.147059,0.274031,0.886505,0.274031,0.886505,0.253658,0.147059,0.253658,0.006026,0.010843,0.007807,0.005958,0.007896,0.008811,0.011071,0.005547,0.011391,0.005958,0.011391,0.005615,0.007875,0.008994,0.010866,0.009633,0.009039,0.008398,0.009724,0.005958,0.010843,0.006209,0.005958,0.009291,0.005958,0.007875,0.009131,0.006437,0.005958,0.010843,0.006209,0.005958,0.011368,0.008811,0.006437,0.005547,0.009039,0.011391,0.006437,0.007533,0.007510,0.011505,0.009108,0.008994,0.005615,0.005684,0.005613,0.008994,0.005958,0.007875,0.010843,0.017577,0.008811,0.006437,0.005547,0.008994,0.005958,0.010112,0.015089,0.007670,0.004497,0.005958,0.018649,0.009039,0.005958,0.008994,0.010843,0.017394,0.010820,0.005615,0.011598,0.009039,0.005958,0.005182,0.010866,0.014723,0.005958,0.008994,0.010866,0.009633,0.009039,0.007898,0.009199,0.009656,0.009039,0.004109]},{w:"cancer genome sketching using Oxford Nanopore sequencing with a machine learning ",p:[0.147059,0.294609,0.886416,0.294609,0.886416,0.274236,0.147059,0.274236,0.009108,0.009085,0.011596,0.008994,0.009039,0.007807,0.005136,0.009656,0.009039,0.011596,0.010843,0.017485,0.009039,0.005136,0.007556,0.010272,0.009131,0.006209,0.008765,0.011459,0.005615,0.011459,0.009861,0.005136,0.011413,0.007601,0.005615,0.011459,0.009861,0.005136,0.016298,0.010089,0.006026,0.010843,0.007442,0.011391,0.005136,0.015545,0.009085,0.011596,0.010820,0.011505,0.010843,0.007442,0.009039,0.005136,0.007875,0.009108,0.010706,0.011345,0.009039,0.011596,0.008994,0.005615,0.011459,0.009861,0.005136,0.014723,0.005271,0.006620,0.011459,0.005136,0.009291,0.005136,0.017577,0.009291,0.008765,0.011459,0.005615,0.011596,0.009039,0.005136,0.005182,0.009291,0.009085,0.007807,0.011756,0.005615,0.011459,0.009861,0.004109]},{w:"approach to detect a set of somatic SVs. We analyzed tumor samples of high-grade ovar-",p:[0.147059,0.315188,0.882353,0.315188,0.882353,0.294815,0.147059,0.294815,0.008811,0.011048,0.011071,0.007442,0.011139,0.009291,0.008765,0.011459,0.004018,0.006209,0.011048,0.004018,0.011322,0.009131,0.006209,0.009108,0.009108,0.006437,0.004018,0.009291,0.004018,0.007875,0.009131,0.006437,0.004018,0.010843,0.006209,0.004018,0.007875,0.010843,0.017577,0.008811,0.006437,0.005547,0.008994,0.004018,0.010112,0.015089,0.007670,0.004497,0.004018,0.018649,0.009039,0.004018,0.009085,0.011687,0.009405,0.005182,0.009724,0.008834,0.009108,0.011391,0.004018,0.006163,0.011413,0.017485,0.010843,0.007807,0.004018,0.007944,0.009085,0.017280,0.011162,0.005182,0.009039,0.007670,0.004018,0.010843,0.006209,0.004018,0.011459,0.005615,0.009930,0.011459,0.007533,0.009861,0.007898,0.009291,0.011322,0.009039,0.004018,0.010866,0.009838,0.009085,0.007257,0.007533]},{w:"ian and prostate cancer patients, successfully identified candidate SVs and validated on ",p:[0.147059,0.335767,0.886441,0.335767,0.886441,0.315394,0.147059,0.315394,0.005798,0.009085,0.011756,0.004976,0.009085,0.011596,0.011391,0.004976,0.011071,0.007442,0.010957,0.007510,0.006551,0.008811,0.006209,0.009039,0.004976,0.009108,0.009085,0.011596,0.008994,0.009039,0.007807,0.004976,0.011368,0.008811,0.006437,0.005547,0.009039,0.011391,0.006437,0.007670,0.004497,0.004976,0.007510,0.011345,0.008994,0.008994,0.009039,0.007533,0.007601,0.006369,0.011550,0.005385,0.005184,0.009724,0.004976,0.005547,0.011322,0.009039,0.011393,0.006437,0.005615,0.005684,0.005613,0.009108,0.011391,0.004976,0.009108,0.009085,0.011596,0.011391,0.005547,0.011573,0.008811,0.006209,0.009039,0.004976,0.010112,0.015089,0.007670,0.004976,0.009085,0.011596,0.011391,0.004976,0.009838,0.009405,0.005250,0.005547,0.011573,0.008811,0.006209,0.009108,0.011391,0.004976,0.010843,0.011756,0.004109]},{w:"average ten somatic SVs per patient with breakpoint-spanning PCR mini-amplicons. ",p:[0.147059,0.356345,0.886484,0.356345,0.886484,0.335972,0.147059,0.335972,0.008925,0.009633,0.009039,0.007898,0.009199,0.009656,0.009039,0.006802,0.006209,0.009039,0.011756,0.006802,0.007875,0.010843,0.017577,0.008811,0.006437,0.005547,0.008994,0.006802,0.010112,0.015089,0.007670,0.006802,0.011505,0.009039,0.007807,0.006802,0.011368,0.008811,0.006437,0.005547,0.009039,0.011391,0.006437,0.006802,0.014723,0.005271,0.006620,0.011459,0.006802,0.010820,0.007442,0.009291,0.009405,0.010272,0.011505,0.010843,0.005615,0.011391,0.006437,0.007533,0.007510,0.011368,0.009085,0.011756,0.011756,0.005615,0.011459,0.009861,0.006802,0.012167,0.014678,0.013376,0.006802,0.017645,0.005615,0.011756,0.005615,0.007533,0.009085,0.017280,0.011162,0.005250,0.005547,0.008994,0.010843,0.011619,0.007670,0.004497,0.004109]},{w:"These SVs could be quantified in ctDNA samples of patients with metastatic prostate ",p:[0.147059,0.376924,0.886441,0.376924,0.886441,0.356551,0.147059,0.356551,0.011470,0.011311,0.009039,0.007875,0.009039,0.006391,0.010112,0.015089,0.007670,0.006391,0.008994,0.010820,0.011550,0.005182,0.011391,0.006391,0.011254,0.009039,0.006391,0.010706,0.011596,0.009085,0.011391,0.006437,0.005615,0.005684,0.005615,0.009108,0.011391,0.006391,0.005615,0.011756,0.006391,0.009108,0.006437,0.015773,0.015408,0.014929,0.006391,0.007941,0.009087,0.017280,0.011162,0.005182,0.009039,0.007670,0.006391,0.010845,0.006209,0.006391,0.011368,0.008811,0.006437,0.005547,0.009039,0.011391,0.006437,0.007670,0.006391,0.014723,0.005273,0.006620,0.011459,0.006391,0.017485,0.009128,0.006551,0.009291,0.007510,0.006551,0.008811,0.006437,0.005547,0.008994,0.006391,0.011071,0.007442,0.010957,0.007510,0.006551,0.008811,0.006209,0.009039,0.004109]},{w:"cancer using a digital PCR assay. The SV quantification in these longitudinal samples ",p:[0.147059,0.397503,0.886484,0.397503,0.886484,0.377130,0.147059,0.377130,0.009108,0.009085,0.011596,0.008994,0.009039,0.007807,0.006414,0.011413,0.007601,0.005615,0.011459,0.009861,0.006414,0.009291,0.006414,0.011391,0.005615,0.009861,0.005271,0.006551,0.009405,0.005250,0.006414,0.012167,0.014678,0.013376,0.006414,0.009291,0.007533,0.007944,0.008925,0.007989,0.004497,0.006414,0.011470,0.011311,0.009039,0.006414,0.010112,0.015089,0.006414,0.010706,0.011596,0.009085,0.011391,0.006437,0.005615,0.005684,0.005615,0.009108,0.008811,0.006437,0.005545,0.010845,0.011756,0.006414,0.005615,0.011756,0.006414,0.006620,0.011299,0.009039,0.007875,0.009039,0.006414,0.005182,0.010843,0.011459,0.009861,0.005273,0.006163,0.011345,0.011391,0.005615,0.011687,0.009405,0.005250,0.006414,0.007944,0.009085,0.017280,0.011162,0.005182,0.009039,0.007670,0.004109]},{w:"suggest that indeed SV dynamics correlate with and may improve other response bio-",p:[0.147059,0.418081,0.882353,0.418081,0.882353,0.397709,0.147059,0.397709,0.007510,0.011413,0.009975,0.009656,0.009039,0.007510,0.006437,0.005775,0.006617,0.011393,0.008811,0.006437,0.005775,0.005615,0.011596,0.011322,0.009108,0.009108,0.011391,0.005775,0.010112,0.015089,0.005775,0.011322,0.009724,0.011687,0.009085,0.017645,0.005547,0.008994,0.007670,0.005775,0.008994,0.010843,0.007807,0.007442,0.008948,0.005433,0.008811,0.006209,0.009039,0.005775,0.014723,0.005271,0.006620,0.011459,0.005775,0.009085,0.011596,0.011391,0.005775,0.017577,0.008928,0.009724,0.005775,0.005615,0.017280,0.011071,0.007442,0.010866,0.009633,0.009039,0.005775,0.010820,0.006620,0.011299,0.009039,0.007807,0.005775,0.007442,0.009039,0.007510,0.011505,0.010843,0.011619,0.007875,0.009039,0.005775,0.010820,0.005547,0.010977,0.007533]},{w:"markers such as PSA. Our work enables rapid and cost-effective identification of a set of ",p:[0.147059,0.438660,0.886459,0.438660,0.886459,0.418287,0.147059,0.418287,0.017577,0.009085,0.007601,0.010272,0.009039,0.007624,0.007670,0.004212,0.007510,0.011345,0.008768,0.011459,0.004209,0.009291,0.007670,0.004212,0.012167,0.010112,0.014929,0.004497,0.004212,0.016504,0.011413,0.007807,0.004212,0.014518,0.010843,0.007601,0.010523,0.004212,0.009039,0.011687,0.009108,0.010911,0.005182,0.009039,0.007670,0.004212,0.007898,0.008811,0.011071,0.005547,0.011391,0.004209,0.009087,0.011596,0.011391,0.004212,0.008994,0.010957,0.007510,0.006437,0.007533,0.009039,0.005969,0.005784,0.009108,0.009108,0.006437,0.005547,0.009633,0.009039,0.004212,0.005547,0.011322,0.009039,0.011391,0.006437,0.005615,0.005684,0.005615,0.009108,0.008811,0.006437,0.005547,0.010843,0.011756,0.004212,0.010843,0.006209,0.004212,0.009291,0.004209,0.007875,0.009131,0.006437,0.004212,0.010843,0.006209,0.004109]},{w:"patient-specific SVs that can be used to study ctDNA dynamics.",p:[0.147059,0.459239,0.680927,0.459239,0.680927,0.438866,0.147059,0.438866,0.011368,0.008811,0.006437,0.005547,0.009039,0.011391,0.006437,0.007533,0.007510,0.011505,0.009108,0.008994,0.005615,0.005684,0.005613,0.008994,0.004109,0.010112,0.015089,0.007670,0.004109,0.006620,0.011391,0.008811,0.006437,0.004109,0.009108,0.009085,0.011756,0.004109,0.011254,0.009039,0.004109,0.011413,0.007873,0.009108,0.011391,0.004109,0.006209,0.011048,0.004109,0.007510,0.006163,0.011345,0.011322,0.009724,0.004109,0.009108,0.006437,0.015773,0.015408,0.014929,0.004109,0.011322,0.009724,0.011687,0.009085,0.017645,0.005547,0.008994,0.007670,0.004497]}]};